Skip to main content
NIH funding notice RFA-AG-23-028

Neuronal Vulnerability to Proteinopathies in Alzheimers Disease and Alzheimers Disease-Related Dementias (R01 Clinical Trial Not Allowed)

Closed on July 15, 2022.

Posted
April 19, 2022
Close date
July 15, 2022
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

7 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $10,184,095 in first-year total cost, median $811,605.

Most frequent study sections

  1. Special Emphasis Panel[ZAG1 ZIJ-D (J1)]6
  2. ZAG1-ZIJ-D(J1)1

Most frequent institutions

  1. UNIVERSITY OF CALIFORNIA, SAN FRANCISCO2
  2. CLEVELAND CLINIC LERNER COM-CWRU1
  3. MASSACHUSETTS GENERAL HOSPITAL1
  4. SALK INSTITUTE FOR BIOLOGICAL STUDIES1
  5. STANFORD UNIVERSITY1
Competing awards under RFA-AG-23-028 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2023Atlas for neuronal and glial cell types selectively vulnerable to proteinopathies during progression of Alzheimer's Disease1R01AG082151-01LEE, KUO-FENSALK INSTITUTE FOR BIOLOGICAL STUDIES, CA$2,790,703ZAG1
2023Multidimensional mapping of vulnerable cell types in humanized Alzheimer's disease mouse models1R01AG082147-01COBOS, INMAPALOP, JORGE JSTANFORD UNIVERSITY, CA$2,354,412ZAG1
2023Single-cell transcriptomic and epigenomic analysis of brain cell vulnerabilities to tauopathies in early AD impacted brain regions1R01AG082127-01KOOB, MICHAEL DREN, BINGXU, XIANGMINUNIVERSITY OF CALIFORNIA-IRVINE, CA$2,094,544ZAG1
2023Characterize neuronal and glial cell-specific vulnerability to proteinopathies in Alzheimer's disease using multimodal single-nuclei genomic and epigenomic approaches1R01AG082118-01BONAKDARPOUR, BORNACHENG, FEIXIONGFLANAGAN, MARGARET EPIEPER, ANDREW ACLEVELAND CLINIC LERNER COM-CWRU, OH$811,605ZAG1
2023Computational dissection of cellular and network vulnerability in Alzheimer's and related dementias1R56AG082087-01RAJ, ASHISHUNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA$760,683ZAG1
2023Molecular mechanisms of selective vulnerability of neurons to tauopathy1R01AG082141-01CONDELLO, CARLO LKAMPMANN, MARTINUNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA$744,445ZAG1
2023Locus coeruleus network architecture of Alzheimer's disease vulnerability1R01AG082006-01JACOBS, HEIDI IRMASEPULCRE, JORGEMASSACHUSETTS GENERAL HOSPITAL, MA$627,703ZAG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

RFA-AG-23-028: Neuronal Vulnerability to Proteinopathies in Alzheimers Disease and Alzheimers Disease-Related Dementias (R01 Clinical Trial Not Allowed) | ScienceDex | ConductScience